Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Asim Bilen

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Cancer|December 30, 2020
Circulating interleukin 6, androgen deprivation therapy, and fatigue in prostate cancer: Is inflammation the link?Bassel Nazha, Mehmet Asim Bilen
Cancer Treatment and Research Communications|December 11, 2020
Immunotherapy in sarcomatoid renal cell carcinoma: A case for optimismJacqueline T Brown, Mehmet Asim Bilen
Ebiomedicine|September 11, 2019
Management of metastatic renal cell carcinoma: The complexity of choiceJacqueline T Brown, Mehmet Asim Bilen
Vaccines|August 15, 2018
Therapeutic Vaccines for Genitourinary MalignanciesGiselle M A Dutcher, Mehmet Asim Bilen
Kidney Cancer (Clifton, Va.)|December 24, 2019
A Review of Papillary Renal Cell Carcinoma and MET InhibitorsKatherine Emilie Rhoades Smith, Mehmet Asim Bilen
Expert Opinion on Investigational Drugs|January 12, 2018
The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinomaMehmet Asim Bilen, Jennifer W Carlisle, Guru Sonpavde
Serican Journal of Medicine|February 9, 2026
Therapeutic targeting of Aurora Kinase A in advanced prostate cancerMaroun Bou Zerdan, Mehmet Asim Bilen, Jindan Yu
Clinical Genitourinary Cancer|July 7, 2011
Prolonged remission of fulminant castrate-resistant prostate cancer: a case reportMehmet Asim Bilen, Rosale General, Shi-Ming Tu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
Combined Programmed Death-Ligand 1 and MET Inhibition: Has Papillary Renal Cell Carcinoma MET Its Match?Jacqueline T Brown, Bassel Nazha, Mehmet Asim Bilen
Biology|April 30, 2021
Inflammatory Markers in Cancer ImmunotherapyDeepak Ravindranathan, Viraj A Master, Mehmet Asim Bilen
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Cancer|December 30, 2020
Circulating interleukin 6, androgen deprivation therapy, and fatigue in prostate cancer: Is inflammation the link?Bassel Nazha, Mehmet Asim Bilen
Cancer Treatment and Research Communications|December 11, 2020
Immunotherapy in sarcomatoid renal cell carcinoma: A case for optimismJacqueline T Brown, Mehmet Asim Bilen
Ebiomedicine|September 11, 2019
Management of metastatic renal cell carcinoma: The complexity of choiceJacqueline T Brown, Mehmet Asim Bilen
Vaccines|August 15, 2018
Therapeutic Vaccines for Genitourinary MalignanciesGiselle M A Dutcher, Mehmet Asim Bilen
Kidney Cancer (Clifton, Va.)|December 24, 2019
A Review of Papillary Renal Cell Carcinoma and MET InhibitorsKatherine Emilie Rhoades Smith, Mehmet Asim Bilen
Expert Opinion on Investigational Drugs|January 12, 2018
The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinomaMehmet Asim Bilen, Jennifer W Carlisle, Guru Sonpavde
Serican Journal of Medicine|February 9, 2026
Therapeutic targeting of Aurora Kinase A in advanced prostate cancerMaroun Bou Zerdan, Mehmet Asim Bilen, Jindan Yu
Clinical Genitourinary Cancer|July 7, 2011
Prolonged remission of fulminant castrate-resistant prostate cancer: a case reportMehmet Asim Bilen, Rosale General, Shi-Ming Tu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
Combined Programmed Death-Ligand 1 and MET Inhibition: Has Papillary Renal Cell Carcinoma MET Its Match?Jacqueline T Brown, Bassel Nazha, Mehmet Asim Bilen
Biology|April 30, 2021
Inflammatory Markers in Cancer ImmunotherapyDeepak Ravindranathan, Viraj A Master, Mehmet Asim Bilen
Pageof 13